These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1695623)

  • 1. Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes.
    Fuller AA; Trevithick JE; Rodey GE; Parham P; Fuller TC
    Hum Immunol; 1990 Jul; 28(3):284-305. PubMed ID: 1695623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes.
    Fuller AA; Rodey GE; Parham P; Fuller TC
    Hum Immunol; 1990 Jul; 28(3):306-25. PubMed ID: 1695624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-A2 epitopes recognized by alloantibodies from broadly sensitized patients.
    Scornik JC
    Hum Immunol; 1987 Apr; 18(4):277-85. PubMed ID: 2437089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
    Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
    J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17.
    Ways JP; Rothbard JB; Parham P
    J Immunol; 1986 Jul; 137(1):217-22. PubMed ID: 2423602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope fine specificity of human anti-HLA-A2 antibodies. Identification of four epitopes including a haptenlike epitope on HLA-A2 at lysine 127.
    De Vito LD; Mason BP; Jankowska-Gan E; Hogan KT; Guo JW; Lutz CT; Sollinger HW; Burlingham WJ
    Hum Immunol; 1993 Jul; 37(3):165-77. PubMed ID: 7503972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antigenic structure of HLA-A2: an analysis with competitive binding assays and monoclonal antibodies.
    Ways JP; Parham P
    J Immunol; 1983 Aug; 131(2):856-63. PubMed ID: 6190942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule.
    Santos-Aguado J; Barbosa JA; Biro PA; Strominger JL
    J Immunol; 1988 Oct; 141(8):2811-8. PubMed ID: 2459229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule.
    Brenner MB; McLean J; Yang SY; van der Poel JJ; Pious D; Strominger JL
    J Immunol; 1985 Jul; 135(1):384-90. PubMed ID: 2582041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
    El-Awar N; Lee JH; Tarsitani C; Terasaki PI
    Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular studies of anti-HLA-A2 using light-chain shuffling: a structural model for HLA antibody binding.
    Watkins NA; Dafforn TR; Kuijpers M; Brown C; Javid B; Lehner PJ; Navarrete C; Ouwehand WH
    Tissue Antigens; 2004 Apr; 63(4):345-54. PubMed ID: 15009806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody recognizing a determinant shared by HLA-A2 and HLA-Aw69 (A28* variant).
    Antonelli P; Choo SY; Nisperos B; Hansen JA
    Tissue Antigens; 1985 Aug; 26(2):114-20. PubMed ID: 2414860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allo-antibodies to an antigenic determinant shared by HLA-A2 and B17.
    Claas F; Castelli-Visser R; Schreuder I; van Rood J
    Tissue Antigens; 1982 May; 19(5):388-91. PubMed ID: 6180520
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedure.
    Fuller TC; Fuller AA; Golden M; Rodey GE
    Hum Immunol; 1997; 56(1-2):94-105. PubMed ID: 9455498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization and characterization of serologic epitopes on HLA-A2.
    Hogan KT; Brown SL
    Hum Immunol; 1992 Mar; 33(3):185-92. PubMed ID: 1377666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2.
    Ways JP; Parham P
    Biochem J; 1983 Nov; 216(2):423-32. PubMed ID: 6197968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenicity of HLA-A2 and HLA-B7. Loss and gain of serologic determinants induced by site-specific mutagenesis at residues 62 to 80.
    Doménech N; Santos-Aguado J; López de Castro JA
    Hum Immunol; 1991 Feb; 30(2):140-6. PubMed ID: 1708752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.